2008Journal of psychiatryRequires access

Meta analysis of comparative study on ziprasidone in the treatment of schizophrenia

LI Jiang-yon

Open publisher page 0 citations

Abstract

Objective To study the efficacy and side effects of ziprasidone in treatment of patients with schizophrenia.Methods A total of 14 comparative studies of ziprasidone and the other antipsychotics in the treatment of patients with schizophrenia were analyzed by meta-analysis in therapeutic effects and side effects.Results The significant difference in symptoms between before and after treatment with ziprasidone was found(d=3.52,95%CI(2.86,4.18),χ2=108.78,P0.01).Comparison between ziprasidone and the other antipsychotics at 2nd weekend after treatment and at the end of trials showed that there was no significant difference with respect to the clinical efficacy.The occurent rate of nausea and vomit in ziprasidone group was significantly higher than that in the other antipsychotics group,but the rates of weight gain and EPS were lower in ziprasidone group.Conclusion Ziprasidone has a similar clinical efficacy comparing with controlled antipsychotics.

About this research paper

What this paper is about

Objective To study the efficacy and side effects of ziprasidone in treatment of patients with schizophrenia.Methods A total of 14 comparative studies of ziprasidone and the other antipsychotics in the treatment of patients with schizophrenia were analyzed by meta-analysis in therapeutic effects and side effects.Results The significant difference in symptoms between before and after treatment with ziprasidone was found(d=3.52,95%CI(2.86,4.18),χ2=108.78,P0.01).Comparison between ziprasidone and the other antipsychotics at 2nd weekend after treatment and at the end of trials showed that there was no significant difference with respect to the clinical efficacy.The occurent rate of nausea and vomit in ziprasidone group was significantly higher than that in the other antipsychotics group,but the rates of weight gain and EPS were lower in ziprasidone group.Conclusion Ziprasidone has a similar clinical efficacy comparing with controlled antipsychotics.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the efficacy and side effects of ziprasidone in treatment of patients with schizophrenia.Methods A total of 14 comparative studies of ziprasidone and the other antipsychotics in the treatment of patients with schizophrenia were analyzed by meta-analysis in therapeutic effects and side effects.Results The significant difference in symptoms between before and after treatment with ziprasidone was found(d=3.52,95%CI(2.86,4.18),χ2=108.78,P0.01).Comparison between ziprasidone and the other antipsychotics at 2nd weekend after treatment and at the end of trials showed that there was no significant difference with respect to the clinical efficacy.The occurent rate of nausea and vomit in ziprasidone group was significantly higher than that in the other antipsychotics group,but the rates of weight gain and EPS were lower in ziprasidone group.Conclusion Ziprasidone has a similar clinical efficacy comparing with controlled antipsychotics.

Key concepts: Ziprasidone, Schizophrenia (object-oriented programming), Significant difference, Nausea, Medicine, Clinical efficacy, Internal medicine, Psychiatry

Related papers

Back to paper searchBrowse research topicsOriginal source
Meta analysis of comparative study on ziprasidone in the treatment of schizophrenia — Research Paper | ScholarLens